Table 3 (A6). Main results from structure and process quality audits of the insulin charts at the University Hospital Graz in 2015
From: Abstracts from the 4th Grazer Risk Day: Patient Safety in Routine
| Â | Structure quality (20 insulin charts in blank form) | Process quality (123 used insulin charts) |
|---|---|---|
patient identification | no marked space provided for label or name (10%) | no patient identification given (17%) |
BG monitoring | option to prescribe BG sampling frequency per day (0%) | performed BG measurements (min.-max.)/day depending on type of therapy: total: 0–15 insulin: 0–15 oral antidiabetic medication: 0–7 diet: 0-5 |
marked space for HbA1cª-field (35%) | HbA1c-value documented (11%) | |
insulin orders | not enough space to document names of used insulins (35%) | name of insulin was not complete/legible/comprehensible (22%) |
administration record | no marked field, to document initials by insulin administration (75%) | insulin administration not signed (70%) |
hypoglycemia management | marked field for hypoglycemia-documentation (0%) | one out of six hypoglycemia treatments was documented (17%) |